Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
July 03, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
June 29, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
May 30, 2018 18:09 ET
|
Akers Biosciences Inc
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Announces a Change to the Board of Directors
May 29, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
May 25, 2018 16:30 ET
|
Akers Biosciences Inc
THOROFARE, N.J., May 25, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
April 12, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Reports Earnings for Fiscal Year 2017
April 03, 2018 07:03 ET
|
Akers Biosciences Inc
Total Revenue Up 33% THOROFARE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health...
Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
March 28, 2018 11:20 ET
|
Akers Biosciences Inc
THOROFARE, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...
Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
March 26, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, has...